Citation Impact
Citing Papers
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
2003 StandoutScience
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
1996
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
1998
Crohn’s disease severity in familial and sporadic cases
1999
Corticosteroids for maintenance of remission in Crohn's disease
2003
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
2010
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
2003 Standout
Smoking Cessation Alters Intestinal Microbiota
2014
Crohn's disease: monitoring disease activity
2003
Environment and the Inflammatory Bowel Diseases
2013
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
2003 Standout
Management of Crohn's disease in adults
2001
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
2010
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data
2006
Ulcerative Colitis
2011 Standout
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs disease
2009
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease
1999
Effects of light smoking consumption on the clinical course of Crohnʼs disease
2008
Environmental Factors in Familial Crohnʼs Disease in Belgium
2005
The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics
2001
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease
2000
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Guidelines for the management of inflammatory bowel disease in adults
2011
Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93
1997
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Predicting relapse in Crohn’s disease: a biopsychosocial model
2008
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
2002
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Efficacy of parenteral methotrexate in refractory Crohn’s disease
2001
IMAGING MODALITIES IN INFLAMMATORY BOWEL DISEASE
1999
Inflammatory bowel disease: cause and immunobiology
2007 Standout
The interface between innate and adaptive immunity
2004 StandoutNobel
A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease
2005
Epidemiology and risk factors for IBD
2015 Standout
Inflammatory Bowel Disease
2009 Standout
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
2008
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2004 Standout
Has disease outcome in Crohn's disease changed during the last four decades?
2004
Smoking cessation and the course of Crohn's disease: An intervention study
2001
Gender differences in the response of colitis to smoking
2004
Inflammatory Bowel Disease and Smoking
2004
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
2002
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Phenotype at diagnosis predicts recurrence rates in Crohn’s disease
2005
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Ulcerative colitis
2012 Standout
Genetic Polymorphisms in Metabolizing Enzymes Modifying the Association Between Smoking and Inflammatory Bowel Diseases
2014
10 Adjuvant post-operative therapy
1998
Colonoscopy in inflammatory bowel disease
2002
Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure
2003
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
Impact of environmental and dietary factors on the course of inflammatory bowel disease
2012
Sleep Duration Affects Risk for Ulcerative Colitis: A Prospective Cohort Study
2014
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
1999
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Evidence that Stress Contributes to Inflammatory Bowel Disease: Evaluation, Synthesis, and Future Directions
2005
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Endoscopy in inflammatory bowel disease
2002
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis
2010
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
2003
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
2003
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Smoking and inflammatory bowel disease
2007
Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial
2005
Long-term Oral Tacrolimus Therapy in Refractory to Infliximab Fistulizing Crohnʼs Disease.
2005
Ulcerative colitis
2016 Standout
Methotrexate in Crohn's Disease: Long-Term Efficacy and Toxicity
2000
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
A Genomewide Analysis Provides Evidence for Novel Linkages in Inflammatory Bowel Disease in a Large European Cohort
1999
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity
2000
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
1998
Family and twin studies in inflammatory bowel disease
2006
Active and Passive Smoking in Childhood Is Related to the Development of Inflammatory Bowel Disease
2006
The Inflammasomes
2010 Standout
Enteral nutritional therapy for induction of remission in Crohn's disease
2001
Current smoking differentially affects blood mononuclear cells from patients with crohnʼs disease and ulcerative colitis: Relevance to its adverse role in the disease
2011
Role of genetic and environmental factors in British twins with inflammatory bowel disease
2011
Review article: altering the natural history of Crohn's disease – evidence for and against current therapies
2006
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
1999
The molecular classification of the clinical manifestations of Crohn's disease
2002
The Genetics of Inflammatory Bowel Disease
2007
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Prior appendectomy and the phenotype and course of Crohn’s disease
2006
Patient Nonadherence To Medication in Inflammatory Bowel Disease
2003
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Points of control in inflammation
2002 StandoutNature
Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease
1994
Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: Safe alternative to surgery
2006
Autoimmunity and Apoptosis
2001 StandoutNobel
NUTRITION AND INFLAMMATORY BOWEL DISEASE
1999
IBD: a family affair
2004
Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect
2014
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
2011
The limitations of corticosteroid therapy in Crohn’s disease
2001
Methotrexate in Refractory Crohnʼs Disease
1999
Guidelines for the management of inflammatory bowel disease in adults
2004
Immunomodulators Are Associated With a Lower Risk of First Surgery Among Patients With Non-Penetrating Non-Stricturing Crohn's Disease
2009
Endoscopic evaluation of patients with inflammatory bowel disease
2008
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence
2009
Adherence to Medication
2005 Standout
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Toll-Like Receptors
2003 Standout
Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
2009
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
2002
Methotrexate for induction of remission in refractory Crohn's disease
2014
Maintenance Therapy in Crohn's Disease
2000
Smoking in inflammatory bowel diseases: Good, bad or ugly?
2007
Are There Any Differences in Phenotype or Disease Course Between Familial and Sporadic Cases of Inflammatory Bowel Disease? Results of a Population-Based Follow-Up Study
2007
Impaired TGF-β Responses in Peripheral T Cells of Gαi2−/− Mice
2005 StandoutNobel
Review article: ulcerative colitis, smoking and nicotine therapy
2012
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
2001
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Long-Term Evolution of Disease Behavior of Crohn's Disease
2002 Standout
Course of Crohn's disease after allogeneic marrow transplantation
1998
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study
2000
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet
2010
Traditional corticosteroids for induction of remission in Crohn's disease
2008
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
Innate Immune Recognition
2002 Standout
Effects of current and former cigarette smoking on the clinical course of Crohn’s disease
1999
The Structure of Haplotype Blocks in the Human Genome
2002 StandoutScience
Preventing postoperative recurrence of Crohn's disease.
1997
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease
2000
Methotrexate in refractory Crohn's disease
2007
Works of Gendre Jp being referenced
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
1992
Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives
1996
Use of anti-tumour necrosis factor agents in inflammatory bowel disease
2001
Methotrexate for the treatment of refractory Crohn's disease.
1996
Effects of cigarette smoking on the long-term course of Crohn's disease
1996
Clinical characteristics of Crohn's disease in 72 families
1996
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
1995
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.
1991
[Comparison of long-term course of perforating and non-perforating Crohn disease].
1999
Mesalamine(M) in Crohn's disease (CD) patients with prednisolone-induced remission: Effect on steroid weaning and remission maintenance in the year after weaning: A placebo-controlled, multicentre double-blind trial
1995
[The risk of extra-colonic extension in Crohn's colitis].
1993
TPQL3: QUALITY OF LIFE IN CROHN DISEASE: A PROSPECTIVE, LONGITUDINAL STUDY IN 231 PATIENTS
1999
[Colonic involvement in ileal Crohn's disease].
1999